Skip to Content

Anti-osteoporotic treatment does reduce the risk of fracture in real-life data

Randomized clinical trials suggest that anti-osteoporotic treatments increase bone mineral density (BMD) and hence reduce the risk of fractures. In this longitudinal cohort study, MD Giovanni Adami, presents the real-life effectiveness of anti-osteoporotic treatment in women at high risk of fracture.

Read more: Abstract: OP0239 Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study.

Giovanni Adami

Få adgang til artiklen

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top